Herrmann Ken
SEC CIK 2049757 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AKTS | Aktis Oncology, Inc. | Dir | 4,856 | — | $196.5K | 4 | 2026-07-17 | 2026-07-20 |
Most active insiders at AKTS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | NODELMAN OLEG | Dir | $40.00M | — |
| 2 | MPM ONCOLOGY INNOVATIONS FUND LP | 10% | $20.03M | — |
| 3 | GADICKE ANSBERT | 10% | $20.03M | — |
| 4 | VIDA VENTURES II-A, LLC | 10% | $15.03M | — |
| 5 | Kim Helen Susan | Dir, 10% | $15.03M | — |
| 6 | Foley Todd | Dir, 10% | $4.19M | — |
| 7 | Czibere Akos | Chief Medical Off | — | $1.65M |
| 8 | Ron-Bigger Shulamit | COO | — | $1.39M |
| 9 | Herrmann Ken | Dir | — | $196.5K |
| 10 | Segal Lloyd Mitchell | Dir | — | — |
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-07-21 20:50 | 2026-07-20 | AKTS | Aktis Oncology, Inc. | Herrmann Ken | Dir | M - OptEx | $0.5888 | +4,856 | 4,856 | New | +$2,859 |
| DM | 2026-07-21 20:50 | 2026-07-20 | AKTS | Aktis Oncology, Inc. | Herrmann Ken | Dir | S - Sale+OE | $24.56 | -4,856 | 0 | -100% | -$119.3K |
| D | 2026-07-20 17:34 | 2026-07-17 | AKTS | Aktis Oncology, Inc. | Herrmann Ken | Dir | M - OptEx | $0.08 | +3,065 | 3,065 | New | +$245.20 |
| D | 2026-07-20 17:34 | 2026-07-17 | AKTS | Aktis Oncology, Inc. | Herrmann Ken | Dir | S - Sale+OE | $25.21 | -3,065 | 0 | -100% | -$77.3K |
Purchase Sale Sale after option exercise All abbreviations